SVB Wealth LLC Invests $1.42 Million in Henry Schein, Inc. $HSIC

SVB Wealth LLC bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 19,364 shares of the company’s stock, valued at approximately $1,415,000.

Other institutional investors have also recently bought and sold shares of the company. Artisan Partners Limited Partnership raised its position in Henry Schein by 0.9% in the second quarter. Artisan Partners Limited Partnership now owns 6,462,204 shares of the company’s stock worth $472,064,000 after purchasing an additional 55,653 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Henry Schein by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock valued at $436,489,000 after purchasing an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Henry Schein by 4.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock valued at $153,480,000 after buying an additional 103,384 shares in the last quarter. Burgundy Asset Management Ltd. grew its stake in Henry Schein by 33.9% during the first quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock worth $153,105,000 after buying an additional 566,530 shares during the last quarter. Finally, Clarkston Capital Partners LLC raised its stake in shares of Henry Schein by 0.4% in the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock valued at $119,965,000 after acquiring an additional 7,345 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on HSIC shares. Barrington Research set a $79.00 price target on Henry Schein and gave the company an “outperform” rating in a report on Wednesday, November 5th. Morgan Stanley increased their price objective on shares of Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a report on Wednesday, November 5th. JPMorgan Chase & Co. boosted their target price on shares of Henry Schein from $76.00 to $78.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Wells Fargo & Company raised their price target on shares of Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a report on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Henry Schein in a report on Thursday. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $76.92.

Henry Schein Stock Performance

HSIC stock opened at $72.86 on Tuesday. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a quick ratio of 0.79, a current ratio of 1.40 and a debt-to-equity ratio of 0.54. The company has a market cap of $8.58 billion, a P/E ratio of 23.06, a price-to-earnings-growth ratio of 2.26 and a beta of 0.89. The business’s fifty day moving average is $68.43 and its 200-day moving average is $69.44.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a return on equity of 14.76% and a net margin of 3.02%.The business had revenue of $3.34 billion during the quarter, compared to the consensus estimate of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.